Vice President, Clinical Operations
Raymond has over 22+ years of drug development experience during which he worked as a clinical research associate and held various management positions for several pharmaceutical companies and clinical research organizations. Prior to joining OncoC4, Raymond oversaw clinical operation for OncoImmune’s Phase III clinical trial that validated safety and clinical efficacy of CD24Fc for COVID-19 patients. Raymond was the Director of Clinical Program Management at Kolon TissueGene. Raymond also spent 10 years at Bristol Myers Squibb where he participated in the implementation of risk-based monitoring, monitored immune-oncology trials and developed strategic alliances with large academic centers across the Northeast of the US. Raymond is well versed in developing and implementing Risk based monitoring overall risk management strategies to clinical trials.